What a $2 Million Per Dose Gene Therapy Reveals About Drug Pricing

—

Taxpayers and charities helped develop Zolgensma. Then it debuted at a record price, ushering in a new class of wildly expensive drugs. Its story upends the widely held conception that high prices reflect huge industry investments in innovation.

https://www.propublica.org/article/zolgensma-sma-novartis-drug-prices-gene-therapy-avexis?utm_source=mastodon&utm_medium=social&utm_campaign=mastodon-post

#News #Health #Healthcare #Medicine #Genetics #Biotech #Science